# Brian Claggett

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/brian-claggett/

## Facts

| Field | Value |
| --- | --- |
| Citations | 47,993 |
| Field | Heart Failure Treatment and Management |
| h-index | 103 |
| i10-index | 509 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5010456790 |
| ORCID iD | 0000-0002-4215-9218 |
| Works | 1,030 |

## Researcher papers

Showing 12 of 19.

- [Spironolactone for Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/spironolactone-for-heart-failure-with-preserved-ejection-fraction/)
- [Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection/)
- [Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-in-heart-failure-with-preserved-ejection/)
- [Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial](https://scholariq.org/papers/regional-variation-in-patients-and-outcomes-in-the-treatment-of-preserved/)
- [SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials](https://scholariq.org/papers/sglt2-inhibitors-in-patients-with-heart-failure-a-comprehensive-meta-analysis-of/)
- [Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis](https://scholariq.org/papers/moving-beyond-the-hazard-ratio-in-quantifying-the-between-group-difference-in/)
- [Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis](https://scholariq.org/papers/dietary-carbohydrate-intake-and-mortality-a-prospective-cohort-study-and-meta/)
- [Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials](https://scholariq.org/papers/estimating-lifetime-benefits-of-comprehensive-disease-modifying-pharmacological/)
- [Sex Differences in Blood Pressure Trajectories Over the Life Course](https://scholariq.org/papers/sex-differences-in-blood-pressure-trajectories-over-the-life-course/)
- [Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure](https://scholariq.org/papers/sacubitril-valsartan-across-the-spectrum-of-ejection-fraction-in-heart-failure/)
- [Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure](https://scholariq.org/papers/renal-effects-and-associated-outcomes-during-angiotensin-neprilysin-inhibition/)
- [Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction](https://scholariq.org/papers/effects-of-sacubitril-valsartan-versus-valsartan-in-women-compared-with-men-with/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Influenza Virus Research Studies](https://scholariq.org/topics/influenza-virus-research-studies/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.